lipodystrophy/gin diare

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 19 rezilta yo

Intestinal lipodystrophy without diarrhea. Report of a case diagnosed by intestinal tube biopsy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND A syndrome of lipodystrophy, characterized by fat redistribution and insulin resistance, has been estimated to affect the majority of human immunodeficiency virus (HIV)-infected individuals who are treated with combination antiretroviral therapy. There are no proven therapies for the

Mesenteric lipodystrophy with fever of unknown origin and mesenteric calcifications.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Mesenteric lipodystrophy (ML) is a rare condition characterized by a nonspecific inflammatory process that involves the root of the mesentery in a lipoma-like lesion. Presenting features of ML include abdominal pain, weight loss, nausea, vomiting, diarrhea, and constipation. This case illustrates

Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signaling.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Aspartyl protease inhibitors (APIs) effectively extend the length and quality of life in human immunodeficiency virus (HIV)-infected patients, but dose-limiting side effects such as lipodystrophy, insulin resistance, and diarrhea have limited their clinical utility. Here, we show that the API

Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Hepatic steatosis is a common complication in patients with lipodystrophies and can lead to cirrhosis. There is no proven effective therapy for hepatic steatosis, but cholic acid (CA), a farnesoid X receptor agonist, has previously been shown to reduce hepatic triglyceride (TG) content in

[Challenges of the anti-retroviral therapy].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Anti-retroviral therapy has still many difficulties for the continuous viral suppression, although it has markedly improved the prognosis of the patients with HIV/AIDS. It is essential that anti-retroviral therapy requires strict adherence of the patients. More than 95% of adherence to have medicine

[The quality of life if HIV/AIDS patients in Iasi Romania].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Quality of life in relation to health is a consequence of disease and treatment on the patient's perception of his ability to have a full and useful life. Due to its nature, the quality of life is a multidimensional and subjective construct, based on the patient's experience. We operationalized the

Life-threatening chronic enteritis due to colonization of the small bowel with Stenotrophomonas maltophilia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Chronic diarrheal illness and malabsorption are challenging diagnostic and clinical problems. The identification of the causative pathogens that are involved in gastrointestinal infections is often difficult. It took 85 years after the first description of a case of intestinal lipodystrophy by Georg

New insights into Whipple's disease - a rare intestinal inflammatory disorder.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Whipple's disease (WD) is a rare systemic infectious disorder caused by the actinomycete Tropheryma whipplei. This chronic disease, first described by Whipple as 'intestinal lipodystrophy', affects preferentially middle-aged white men who may present with weight loss, diarrhea, abdominal pain and

Atazanavir/ritonavir: a review of its use in HIV therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Recommendations for a highly active antiretroviral therapy (HAART) in either pretreated patients or symptomatic patients with an AIDS-defining event are based on a combination of three or more agents from different antiretroviral classes including two nucleoside reverse transcriptase inhibitors with

Side effects of HIV therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The use of highly active effective antiretroviral therapies (ART) has dramatically decreased the morbidity and mortality of the HIV infection. Over 20 anti-retroviral substances are available in four different classes. Side effects of HIV therapy are common and may influence the prognosis, as the

Plasma citrulline is a biomarker of enterocyte mass and an indicator of parenteral nutrition in HIV-infected patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Plasma citrulline is a biomarker of enterocyte mass and function in humans. OBJECTIVE We evaluated citrulline in the reemerging context of diarrhea in HIV-infected patients receiving highly active antiretroviral therapy. METHODS This study prospectively measured citrulline in 6 groups of

[Neurologic disorders in Whipple's disease].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The disease is named after George H. Whipple who, in 1907, was the first to describe an intestinal "lipodystrophy". Although Whipple's disease is generally recognized as a multisystem chronic granulomatous disease, primarily involving the digestive system, it can also appear as a primary

L-Carnitine and acetyl-L-carnitine in the treatment of complications associated with HIV infection and antiretroviral therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

L-Carnitine (LC) and acetyl-L-carnitine (ALC) play major roles in cell energy and lipid metabolism. Supplementation with these nutrients, which are highly popular in USA, has been associated with favorable effects, including anti-oxidant action, neuro- and cardioprotection, immunomodulation, and

[Plasma homocysteine in human immunodeficiency virus infected patient].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Weak hyperhomocysteinemia is a risk factor for the development of atherothrombotic vascular complication. Their plasma levels are affected by nutritional and pharmacologic factors, tobacco, certain metabolic state and gender. In HIV+ patients, the wasting syndrome or chronic diarrheas could affect

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye